Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in Children with PCDH19 Female Pediatric Epilepsy
2015-001324-36Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Apr 2015
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ganaxolone in epilepsy, sponsored by Marinus Pharmaceuticals. Primary endpoint: Percentage change in seizure frequency. Started Apr 2015; status: completed.
02
Drugs
ganaxolone
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2015-001324-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001324-36.